Ernst Rietschel - Concepedia

Author

Ernst Rietschel

Research Center Borstel - Leibniz Lung Center

Also Known As

Bernhard Przybilla, Christian Gieger, E Th Rietschel, ERNST RIETSCHEL, ERNST TH. RIETSCHEL, Ernst Rietschel, Ernst T Rietschel, Ernst T. H. Rietschel, Ernst T. RIETSCHEL, Ernst T. Rietschel

256

Publications

17.1K

Citations

H-Index

152

Concepts

All Affiliations

Research Center Borstel - Leibniz Lung Center University Hospital Cologne University of Cologne Medizinische Hochschule Hannover Max Planck Institute of Immunobiology and Epigenetics

About

Ernst Rietschel is an author at Research Center Borstel - Leibniz Lung Center specializing in medicine, biochemistry, and microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	37	59	6.8K
2	Engineering	12	12	1.3K
3	Health Sciences	5	5	426
4	Arts	1	1	13
5	Language Studies	1	1	54

Ernst Rietschel

123

Publications

11.4K

Citations

H-Index

Page 1

	Year	Citations
Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma Miriam F. Moffatt, Michael Kabesch, Liming Liang, Nature AsthmaGenetic VariantsAllergyChildhood AsthmaGenetics	2007	1.6K
Synthetic and natural <i>Escherichia coli</i> free lipid A express identical endotoxic activities Chris Galanos, O. Lüderitz, Ernst Rietschel, European Journal of Biochemistry Lipid AnalysisLipid PreparationBiosynthesisE. ColiProstaglandin Synthesis	1985	488
A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial Michael Boyle, Scott C. Bell, Michael W. Konstan, The Lancet Respiratory Medicine PathologyCftr CorrectorPulmonary FibrosisMedicinePhe508del Cftr Mutation	2014	436
Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial Eitan Kerem, Michael W. Konstan, K. De Boeck, The Lancet Respiratory Medicine AllergyPlacebo-controlled Phase 3Clinical TrialsNonsense-mutation Cystic FibrosisMedicine	2014	333
Biological activities of lipopolysaccharides are determined by the shape of their lipid A portion Andra B. Schromm, Klaus Brandenburg, Harald Loppnow, European Journal of Biochemistry	2000	317
Invited review: Bacterial lipopolysaccharides and innate immunity Christian Alexander, Ernst Rietschel Journal of Endotoxin Research Proteinlipid InteractionLipid BiophysicsMicrobial PathogensInnate Immune SystemImmunology	2001	304
Nature and Linkages of the Fatty Acids Present in the Lipid‐A Component of <i>Salmonella</i> Lipopolysaccharides Ernst Rietschel, Horst Gotter, O. Lüderitz, European Journal of Biochemistry Lipid AnalysisBioorganic ChemistryLipid MetabolismBiochemistryFatty Acids	1972	242
Interaction of Lipopolysaccharides and Lipid A with Complement Chris Galanos, Ernst Rietschel, O. Lüderitz, European Journal of Biochemistry Lipid AnalysisComplement SystemFood PreservativesBiochemistryMedicine	1971	237
Absence of Oxalobacter formigenes in cystic fibrosis patients: a risk factor for hyperoxaluria Harmeet Sidhu, Bernd Hoppe, Albrecht Hesse, The Lancet Cystic Fibrosis PatientsPathologyRisk FactorPulmonary FibrosisOxalobacter Formigenes	1998	236
Guideline for acute therapy and management of anaphylaxis Johannes Ring, Kirsten Beyer, Tilo Biedermann, Allergo Journal International Allergy MedicineMedicineAcute CarePatient SafetyAcute Therapy	2014	217

Page 1